| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72450feb849ae38d3f567fa0635776ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e88b5bdcc77f65ae734ebaacffeef1ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-706 |
| filingDate |
2015-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce732c8fa8d8b4c2d5cf2735758b92bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca6d3cca391d68b45a2561720a865b2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1995c091e417d0dff8d3b35f09db85de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f66f011e0109ad380ac15a17fc19ecd |
| publicationDate |
2017-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112017000301-A2 |
| titleOfInvention |
treatment of leukemia with histone deacetylase inhibitors |
| abstract |
Combinations are provided herein comprising an hdac and azacitidine inhibitor for treating leukemia in an individual in need thereof. Combinations are provided herein comprising an hdac and azacitidine inhibitor for the treatment of acute myelogenous leukemia in an individual in need thereof. Also provided are methods for treating leukemia in an individual in need thereof, comprising administering to the individual an effective amount of the above combination or an hdac inhibitor, as well as methods for treating acute myelogenous leukemia in an individual in need thereof. administer to the subject an effective amount of the above combination or an hdac inhibitor. |
| priorityDate |
2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |